<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6541">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01906203</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0163</org_study_id>
    <nct_id>NCT01906203</nct_id>
  </id_info>
  <brief_title>Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance</brief_title>
  <acronym>IMPETRAIL</acronym>
  <official_title>Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Estaing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective cohort, monocentric non-randomized and interventional clinical study in ICU
      assessing the evolution of body composition using bioelectrical impedance analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, monocentric non-randomized and interventional clinical study in ICU assessing
      the evolution of body composition using bioelectrical impedance analysis (phase angle, fat
      mass, muscle mass, fat-free mass, body water) before and after ultramarathon.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Difference of fat-free mass, using bioelectrical impedance analysis</measure>
    <time_frame>before and after ultramarathon of 105 km (at day 1)</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference of phase angle, using bioelectrical impedance analysis</measure>
    <time_frame>at day 1(before and after ultramarathon)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between order in the course,duration of course and indices of body composition</measure>
    <time_frame>at day 1 (during ultramarathon of 105 km)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>ultramarathon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>body bioelectrical impedance performed by Z-Métrix (class IIa)  - BIOPARHOM 12 allée des lacs de garde, Savoie Technolac BP 238, 73374 Bourget du lac, France</intervention_name>
    <arm_group_label>ultramarathon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participation to ultramarathon

        Exclusion Criteria:

          -  pregnancy women
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sébastien PERBET</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04.73.75.11.95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04.73.75.11.95</phone>
      <email>placarin@chu-clemrontferrand.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 26, 2013</lastchanged_date>
  <firstreceived_date>July 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ultramarathon</keyword>
  <keyword>bioelectrical impedance</keyword>
  <keyword>Phase-Angle</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
